DISEASE INDICATIONS: Risk of cardiovascular events, Hypertriglyceridemia

MANUFACTURER: Amarin Pharma Inc:

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Vascepa (icosapent ethyl) helps lower triglyceride levels by reducing the production of VLDL cholesterol. It was approved by the FDA in 2012 and is used in high triglyceride level patients.